Rescriptor (delavirdine), another antiviral for HIV
The FDA just approved Rescriptor (delavirdine), another antiviral for HIV...from Pharmacia & Upjohn.
Rescriptor is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).
These drugs inhibit reverse transcriptase...the same enzyme that is inhibited by AZT.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote